Helen C Wang, MD | |
12750 Horseferry Rd Ste 100, Carmel, IN 46032-7265 | |
(317) 795-0707 | |
(317) 564-4438 |
Full Name | Helen C Wang |
---|---|
Gender | Female |
Speciality | Allergy/immunology |
Experience | 23 Years |
Location | 12750 Horseferry Rd Ste 100, Carmel, Indiana |
Accepts Medicare Assignments | May be. She may accept the Medicare-approved amount; you may be billed for more than the Medicare deductible and coinsurance. |
Identifier | Type | State | Issuer |
---|---|---|---|
1730126921 | NPI | - | NPPES |
101554679 | Medicaid | PA |
Taxonomy | Type | License (State) | Status |
---|---|---|---|
207K00000X | Allergy & Immunology | MD423851 (Pennsylvania) | Primary |
Entity Name | Carmel Allergy Llc |
---|---|
Entity Type | Part B Supplier - Clinic/group Practice |
Entity Identifiers | NPI Number: 1215434774 PECOS PAC ID: 5395091938 Enrollment ID: O20180711003768 |
News Archive
Shire plc, the global specialty biopharmaceutical company, announces it has received Fast Track designation from the FDA for REPLAGAL(R) (agalsidase alfa), its enzyme replacement therapy for Fabry disease.
"How is it we can run the country with a 16-page Constitution yet it takes 2,074 pages and more than 400,000 words of gobbledygook to present the Senate Health Care Bill?" asks Alan Siegel, one of the founders of the Plain English and Simplification movements and Chairman and CEO of brand consultancy Siegel+Gale.
A new report from the Kaiser Family Foundation, titled "Innovative Financing Mechanisms for Global Health: Overview and Considerations for U.S. Government Participation," "examines some of the most prominent new financing mechanisms for global health across a broad range of categories, with particular attention to the current level of U.S. government involvement," according to a KFF press release.
Sanovas, Inc., (www.sanovas.com) a life science technology company focused on developing and commercializing next generation micro-invasive diagnostics, devices and drug delivery technologies announced today that the United States Patent and Trademark Office issued patent # 8,597,239 for the company's Abrading Balloon Catheter for Extravasated Drug Delivery.
› Verified 6 days ago
Mailing Address | Practice Location Address |
---|---|
Helen C Wang, MD 12750 Horseferry Rd Ste 100, Carmel, IN 46032-7265 Ph: (317) 795-0707 | Helen C Wang, MD 12750 Horseferry Rd Ste 100, Carmel, IN 46032-7265 Ph: (317) 795-0707 |
News Archive
Shire plc, the global specialty biopharmaceutical company, announces it has received Fast Track designation from the FDA for REPLAGAL(R) (agalsidase alfa), its enzyme replacement therapy for Fabry disease.
"How is it we can run the country with a 16-page Constitution yet it takes 2,074 pages and more than 400,000 words of gobbledygook to present the Senate Health Care Bill?" asks Alan Siegel, one of the founders of the Plain English and Simplification movements and Chairman and CEO of brand consultancy Siegel+Gale.
A new report from the Kaiser Family Foundation, titled "Innovative Financing Mechanisms for Global Health: Overview and Considerations for U.S. Government Participation," "examines some of the most prominent new financing mechanisms for global health across a broad range of categories, with particular attention to the current level of U.S. government involvement," according to a KFF press release.
Sanovas, Inc., (www.sanovas.com) a life science technology company focused on developing and commercializing next generation micro-invasive diagnostics, devices and drug delivery technologies announced today that the United States Patent and Trademark Office issued patent # 8,597,239 for the company's Abrading Balloon Catheter for Extravasated Drug Delivery.
› Verified 6 days ago